We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q4 Potential of Eastman Chemical (EMN): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Eastman Chemical (EMN - Free Report) will report quarterly earnings of $1.28 per share in its upcoming release, pointing to a year-over-year increase of 43.8%. It is anticipated that revenues will amount to $2.17 billion, exhibiting a decline of 8.7% compared to the year-ago quarter.
The current level reflects a downward revision of 1.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Eastman Chemical metrics that are routinely monitored and predicted by Wall Street analysts.
It is projected by analysts that the 'Net Sales- Chemical Intermediates' will reach $476.15 million. The estimate suggests a change of -22.6% year over year.
The average prediction of analysts places 'Net Sales- Advanced Materials' at $707.88 million. The estimate indicates a year-over-year change of -3.8%.
The consensus among analysts is that 'Net Sales- Additives & Functional Products' will reach $627.79 million. The estimate indicates a change of -11% from the prior-year quarter.
The combined assessment of analysts suggests that 'Net Sales- Fibers' will likely reach $351.18 million. The estimate points to a change of +10.8% from the year-ago quarter.
Analysts expect 'Adjusted EBIT- Additives & Functional Products' to come in at $59.74 million. The estimate is in contrast to the year-ago figure of $64 million.
Analysts forecast 'Adjusted EBIT- Advanced Materials' to reach $98.88 million. Compared to the current estimate, the company reported $43 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Adjusted EBIT- Chemical Intermediates' should come in at $17.35 million. The estimate is in contrast to the year-ago figure of $36 million.
Analysts' assessment points toward 'Adjusted EBIT- Fibers' reaching $109.58 million. The estimate compares to the year-ago value of $58 million.
Shares of Eastman Chemical have experienced a change of -5.5% in the past month compared to the +2.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), EMN is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unlocking Q4 Potential of Eastman Chemical (EMN): Exploring Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Eastman Chemical (EMN - Free Report) will report quarterly earnings of $1.28 per share in its upcoming release, pointing to a year-over-year increase of 43.8%. It is anticipated that revenues will amount to $2.17 billion, exhibiting a decline of 8.7% compared to the year-ago quarter.
The current level reflects a downward revision of 1.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Eastman Chemical metrics that are routinely monitored and predicted by Wall Street analysts.
It is projected by analysts that the 'Net Sales- Chemical Intermediates' will reach $476.15 million. The estimate suggests a change of -22.6% year over year.
The average prediction of analysts places 'Net Sales- Advanced Materials' at $707.88 million. The estimate indicates a year-over-year change of -3.8%.
The consensus among analysts is that 'Net Sales- Additives & Functional Products' will reach $627.79 million. The estimate indicates a change of -11% from the prior-year quarter.
The combined assessment of analysts suggests that 'Net Sales- Fibers' will likely reach $351.18 million. The estimate points to a change of +10.8% from the year-ago quarter.
Analysts expect 'Adjusted EBIT- Additives & Functional Products' to come in at $59.74 million. The estimate is in contrast to the year-ago figure of $64 million.
Analysts forecast 'Adjusted EBIT- Advanced Materials' to reach $98.88 million. Compared to the current estimate, the company reported $43 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Adjusted EBIT- Chemical Intermediates' should come in at $17.35 million. The estimate is in contrast to the year-ago figure of $36 million.
Analysts' assessment points toward 'Adjusted EBIT- Fibers' reaching $109.58 million. The estimate compares to the year-ago value of $58 million.
View all Key Company Metrics for Eastman Chemical here>>>
Shares of Eastman Chemical have experienced a change of -5.5% in the past month compared to the +2.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), EMN is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>